Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (388)	10/28/2008 11:50:22 AM
From: tuck	Read Replies (1) \| Respond to of 566

>>I guess the perception is that small molecules don't look any better than competitive biologicals and that Gower can't deliver a partner. CS still believes otherwise (thanks!).<< But RBC does not. They initiated with an "Outperform" in early September, and are downgrading to "Sector Perform" this morning. I was lamenting a missed opportunity to buy at $13 and change the other day . . . dodged THAT bullet. But taking shots from elsewhere. Cheers, Tuck